Mga Batayang Estadistika
| CIK | 890725 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to GelStat Corp.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| April 29, 2025 |
CONSENT OF INDEPENDENT ACCOUNTANT Exhibit 11.1 924 W. 75th Street Suite 120 - 189 Naperville, IL 60565 +1 (815) 348-2421 [email protected] CONSENT OF INDEPENDENT ACCOUNTANT To the Management of GELSTAT CORPORATION I hereby consent to the inclusion in the Offering Circular filed under Regulation A on Form 1-A of my report dated April 23, 2025, with respect to the Balance Sheet of GELSTAT CORPORATION as of December 31, 2024 & Decemb |
|
| April 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 1−K ANNUAL REPORT PURSUANT TO REGULATION A OF THE SECURITIES ACT OF 1933 For the year ended December 31, 2024 GelStat Corp. (Exact name of issuer as specified in its charter) Delaware 90-0075732 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 333 SE 2nd Avenue, Suite 200 |
|
| September 26, 2024 |
UNITED STATES SECURITES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 1-SA þ SEMIANNUAL REPORT PURSUANT TO REGULATION A or ¨ SPECIAL FINANCIAL REPORT PURSUANT TO REGULATION A For the fiscal semiannual period ended June 30, 2024 GelStat Corp. (Exact name of issuer as specified in its charter) Delaware 90-0075732 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer I |
|
| May 7, 2024 |
CONSENT OF INDEPENDENT ACCOUNTANT 924 W. 75th Street Suite 120 - 189 Naperville, IL 60565 +1 (815) 348-2421 [email protected] CONSENT OF INDEPENDENT ACCOUNTANT To the Management of GELSTAT CORPORATION I hereby consent to the inclusion in the Offering Circular filed under Regulation A on Form 1-A of my report dated April 25, 2024, with respect to the Balance Sheet of GELSTAT CORPORATION as of December 31, 2023 & December 31, 2022, |
|
| May 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 1−K ANNUAL REPORT PURSUANT TO REGULATION A OF THE SECURITIES ACT OF 1933 For the year ended December 31, 2023 GelStat Corp. (Exact name of issuer as specified in its charter) Delaware 90-0075732 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 333 SE 2nd Avenue, Suite 200 |
|
| May 7, 2024 |
Exhibit 4.12 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of January 1, 2024, by and between GelStat Corporation., a Delaware corporation with its principal place of business located at 333 SE 2nd Avenue, Suite 2000, Miami, Florida 33131 (the “Company”), and Javier G. Acosta, an individual and resident of the State of Florida (“Executive” and togethe |
|
| October 12, 2023 |
Exhibit 4.10 DUOS NOTE NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMEN |
|
| October 12, 2023 |
Exhibit 99.1 FOR IMMEDIATE RELEASE GSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies Group GelStat’s Subsidiary, GSAC Engineering, Launches Intelligent Correctional Facilities Automation Systems (iCAS) in the Industrial Security Market Miami, FL / GlobeNewswire / September 12, 2023 – GelStat Corporation ("GelStat" or the "Company") (OTCPink: GSAC), a development |
|
| October 12, 2023 |
Exhibit 4.11 DUOS WARRANT AGREEMENT NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT |
|
| October 12, 2023 |
Exhibit 4.9 ASSET PURCHASE AGREEMENT THIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made as of June 28, 2023 (the “Effective Date”), is entered into by and between Duos Technologies, Inc., a Florida corporation (“Seller”), and GelStat Corporation, a Delaware corporation (the “Buyer”). WHEREAS, Seller is, among other things, engaged through one of its business units in the provision of industr |
|
| October 12, 2023 |
Exhibit 4.7 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| October 12, 2023 |
Exhibit 4.8 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE S |
|
| October 12, 2023 |
UNITED STATES SECURITES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 1-SA þ SEMIANNUAL REPORT PURSUANT TO REGULATION A or ¨ SPECIAL FINANCIAL REPORT PURSUANT TO REGULATION A For the fiscal semiannual period ended June 30, 2023 GelStat Corp. (Exact name of issuer as specified in its charter) Delaware 90-0075732 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer I |
|
| May 10, 2023 |
CONSENT OF INDEPENDENT ACCOUNTANT 924 W. 75th Street Suite 120 - 189 Naperville, IL 60565 +1 (815) 348-2421 [email protected] CONSENT OF INDEPENDENT ACCOUNTANT To the Management of GELSTAT CORPORATION I hereby consent to the inclusion in the Offering Circular filed under Regulation A on Form 1-A of my report dated May 4, 2023, with respect to the Balance Sheet of GELSTAT CORPORATION as of December 31, 2022, and the related Profit |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 1−K ANNUAL REPORT PURSUANT TO REGULATION A OF THE SECURITIES ACT OF 1933 For the year ended December 31, 2022 GelStat Corp. (Exact name of issuer as specified in its charter) Delaware 90-0075732 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 333 SE 2nd Avenue, Suite 200 |
|
| May 10, 2023 |
Exhibit 4.5 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE S |
|
| October 3, 2022 |
Common Stock Purchase Agreement between the Company and Accredited Investor dated July 22, 2022 Exhibit 4.6 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| October 3, 2022 |
Convertible Promissory Note between the Company and Accredited Investor dated July 22, 2022 Exhibit 4.5 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE S |
|
| October 3, 2022 |
UNITED STATES SECURITES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 1-SA ? SEMIANNUAL REPORT PURSUANT TO REGULATION A or ? SPECIAL FINANCIAL REPORT PURSUANT TO REGULATION A For the fiscal semiannual period ended June 30, 2022 GelStat Corp. (Exact name of issuer as specified in its charter) Delaware 90-0075732 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer I |
|
| May 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 1−K ANNUAL REPORT PURSUANT TO REGULATION A OF THE SECURITIES ACT OF 1933 For the year ended December 31, 2021 GelStat Corp. (Exact name of issuer as specified in its charter) Delaware 90-0075732 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 7554 SW Jack James Drive, St |
|
| May 2, 2022 |
Common Stock Purchase Agreement between the Company and Accredited Investor dated February 23, 2022 EXHIBIT 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| May 2, 2022 |
Convertible Promissory Note between the Company and Accredited Investor dated February 23, 2022 EXHIBIT 4.4 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE S |
|
| December 15, 2021 |
Re: Securities Registered under Offering Statement on Form 1-A EXHIBIT 12.1 December 15, 2021 GelStat Corporation Attention: Javier Acosta 7554 SW Jack James Drive Stuart, Florida 34997 Re: Securities Registered under Offering Statement on Form 1-A Ladies and Gentlemen: Lucosky Brookman LLP (“we” and “our”) has acted as special counsel to GelStat Corporation, a Delaware corporation (the “Company”), in connection with its filing of an Offering Statement on For |
|
| December 15, 2021 |
AN OFFERING STATEMENT PURSUANT TO REGULATION A RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. |
|
| December 15, 2021 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EXHIBIT 11.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the inclusion in this Registration Statement on Amended Form 1-A of our report dated August 27, 2021, relating to the financial statements of GelStat Corporation for the years ended December 31, 2020 and 2019. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going |
|
| December 15, 2021 |
GelStat Corporation 7554 SW Jack James Drive Stuart, Florida 34997 GelStat Corporation 7554 SW Jack James Drive Stuart, Florida 34997 December 15, 2021 VIA EDGAR U. |
|
| November 24, 2021 |
Security Agreement between Company and Quick Capital, LLC EXHIBIT 4.2 |
|
| November 24, 2021 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EXHIBIT 11.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the inclusion in this Registration Statement on Amended Form 1-A of our report dated August 27, 2021, relating to the financial statements of GelStat Corporation for the years ended December 31, 2020 and 2019. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going |
|
| November 24, 2021 |
AN OFFERING STATEMENT PURSUANT TO REGULATION A RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. |
|
| November 24, 2021 |
Re: Securities Registered under Offering Statement on Form 1-A EXHIBIT 12.1 November 23, 2021 GelStat Corporation Attention: Javier Acosta 7554 SW Jack James Drive Stuart, Florida 34997 Re: Securities Registered under Offering Statement on Form 1-A Ladies and Gentlemen: Lucosky Brookman LLP (“we” and “our”) has acted as special counsel to GelStat Corporation, a Delaware corporation (the “Company”), in connection with its filing of an Offering Statement on For |
|
| October 29, 2021 |
Form of Subscription Agreement EXHIBIT 4.1 GELSTAT CORP. SUBSCRIPTION AGREEMENT THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, SUBSCRIBERS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD |
|
| October 29, 2021 |
GELSTAT CORPORATION Article I. Meetings of Shareholders EXHIBIT 2.4 BYLAWS OF GELSTAT CORPORATION Article I. Meetings of Shareholders Section 1. Annual Meeting. The annual meeting of the shareholders of this Corporation shall be held at the time and place designated by the Board of Directors of the Corporation. Business transacted at the annual meeting shall include the election of directors of the Corporation. Section 2. Special Meetings. Special meet |
|
| October 29, 2021 |
EXHIBIT 2.5 AGREEMENT OF MEGER AND PLAN OF MERGER AND REORGANIZATION This Agreement of Merger and Plan of Merger and Reorganization (this ?Agreement?) is made as of this 17th day of September 2010, by and between GelStat Corporation (?Gel-MN?) (a Minnesota corporation) and GelStat Corporation (?Gel-DE?) (a Delaware corporation), (together, the ?Constituent Corporations?). WHEREAS, the respective b |
|
| October 29, 2021 |
Certificate of Designation of Series A Preferred Stock filed July 6, 2021 EXHIBIT 3.1 |
|
| October 29, 2021 |
Certificate of Amendment to Certificate of Incorporation filed June 22, 2021 EXHIBIT 2.3 |
|
| October 29, 2021 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EXHIBIT 11.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the inclusion in this Registration Statement on Form 1-A of our report dated August 27, 2021, relating to the financial statements of GelStat Corporation for the years ended December 31, 2020 and 2019. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern |
|
| October 29, 2021 |
Certificate of Merger of Foreign Corporation into a Domestic Corporation EXHIBIT 2.6 |
|
| October 29, 2021 |
EXHIBIT 2.1 |
|
| October 29, 2021 |
AN OFFERING STATEMENT PURSUANT TO REGULATION A RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. |
|
| October 29, 2021 |
Certificate of Amendment to Certificate of Incorporation filed May 16, 2011 EXHIBIT 2.2 |
|
| November 21, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K/A Amendment No. 1 ——————— S ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2007 OR £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission file number: |
|
| November 21, 2012 |
3557 SW Corporate Parkway . Palm City, FL 34990 . (P) 772-283-0020 . (F) 772-219-3579 . (E) [email protected] Date: November 21, 2012 Jim B. Rosenberg Senior Assistant Chief Accountant United States Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549-6010 RE: GelStat Corporation Form 10-K for the fiscal year ended December 31, 2008 Filed October 22, 2012 Form 10-K for the f |
|
| November 21, 2012 |
3557 SW Corporate Parkway . Palm City, FL 34990 . (P) 772-283-0020 . (F) 772-219-3579 . (E) [email protected] Date: November 21, 2012 Jim B. Rosenberg Senior Assistant Chief Accountant United States Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549-6010 RE: GelStat Corporation Form 10-K for the fiscal year ended December 31, 2008 Filed October 22, 2012 Form 10-K for the f |
|
| November 21, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K/A Amendment No. 1 ——————— S ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2008 OR £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission file number: |
|
| October 22, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2008 OR £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-21394 Gelstat Corporation (E |
|
| October 22, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2008 OR £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-21394 Gelstat Corporati |
|
| October 22, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2007 OR £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-21394 Gelstat Corporati |
|
| October 22, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-K ??????? S ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2008 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission file number: 000-21394 GelStat |
|
| October 22, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K ——————— S ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2007 OR £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission file number: 000-21394 GelStat |
|
| October 22, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2008 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-21394 Gelstat Corporation ( |
|
| October 22, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2007 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-21394 Gelstat Corporation ( |
|
| October 22, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2007 OR £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-21394 Gelstat Corporation (E |
|
| October 19, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2006 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-21394 Gelstat Corporation (E |
|
| October 19, 2012 |
10-K 1 gelstat10k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K ——————— S ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2006 OR £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission file num |
|
| October 19, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2006 OR £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-21394 Gelstat Corporati |
|
| October 18, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2006 OR £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-21394 Gelstat Corporation ( |
|
| October 5, 2012 |
GELSTAT CORPORATION Article I. Meetings of Shareholders Exhibit 3.5 BYLAWS OF GELSTAT CORPORATION Article I. Meetings of Shareholders Section 1. Annual Meeting. The annual meeting of the shareholders of this Corporation shall be held at the time and place designated by the Board of Directors of the Corporation. Business transacted at the annual meeting shall include the election of directors of the Corporation. Section 2. Special Meetings. Special meet |
|
| October 5, 2012 |
EXHIBIT 3.4 STATE OF DELAWARE CERTIFICATE OF MERGER OF FOREIGN CORPORATION INTO A DOMESTIC CORPORATION Pursuant to Title 8, Section 252 of the Delaware General Corporation Law, the undersigned corporation executed the following Certificate of Merger: FIRST: The name of the surviving corporation is GelStat Corporation, a Delaware corporation, and the name of the corporation being merged into this s |
|
| October 5, 2012 |
Certificate of Amendment to Certificate of Incorporation - Increased Capital Exhibit 3.2 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF GELSTAT CORPORATION GelStat Corporation (the “Company”), a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Delaware General Corporation Law”), hereby certifies as follows:: 1. The Company was incorporated by the filing of a Certificate of Incorporation with the Secretary |
|
| October 5, 2012 |
Exhibit 3.1 CERTIFICATE OF INCORPORATION OF GELSTAT CORPORATION 1. The name of the corporation is GelStat Corporation (the “Company”). 2. The address of its registered office in the State of Delaware, County of New Castle, is 3411 Silverside Road, Rodney Building #104, Wilmington, Delaware 19810. The name of its registered agent at such address is Corporate Creations Network, Inc. 3. The nature of |
|
| October 5, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-K ——————— S ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2005 OR £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission file number: 000-21394 GelStat |
|
| October 5, 2012 |
Exhibit 21.0 List of Subsidiaries Name Place of Incorporation GS Pharma, Inc. 1650 West 82nd Street, Suite 1200 Bloomington, MN 55431 |
|
| October 5, 2012 |
Plan of Merger and Reorganization - Delaware Exhibit 3.3 AGREEMENT OF MERGER AND PLAN OF MERGER AND REORGANIZATION This Agreement of Merger and Plan of Merger and Reorganization (this “Agreement”) is made as of this 17th day of September 2010, by and between GelStat Corporation (“Gel-MN”) (a Minnesota corporation) and GelStat Corporation (“Gel-DE”) (a Delaware corporation), (together, the “Constituent Corporations”). WHEREAS, the respective |
|
| October 5, 2012 |
Exhibit 14.0 Code of Ethics Introduction These Ethical Guidelines will serve as the Code of Ethics (“Guidelines”) for GelStat Corporation (the “Company”) and as such they cover a wide spectrum of business practices and procedures. They do not cover every issue that may arise, but they set out some basic principles to guide all employees and directors of the Company. We expect all of our employees |
|
| January 16, 2009 |
Form 15-12G GelStat Corporation - GSAC Filed: January 16, 2009 (period: ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 2, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: April 27, 2007 (Date of earliest event reported) GELSTAT CORPORATION (Exact name of registrant as specified in its charter) Minnesota 0-21394 90-0075732 (State of other jurisdiction of incorporation) (Commission File |
|
| July 15, 2003 |
EXHIBIT 99.3 UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS FOR THE YEAR ENDED DECEMBER 31, 2002 (Unaudited) DEVELOPED TECHNOLOGY GELSTAT ADJUSTING RESOURCE CORP. ENTRIES PRO FORMA - - - - Cost and Expenses: General and administrative 144,427 153,207 - 297,634 Non-cash stock compensation expense 12,282 - - 12,282 - - - - 156 |
